Literature DB >> 1956783

Multiple positive and negative elements regulate human brain creatine kinase gene expression.

M E Ritchie1, R V Trask, H L Fontanet, J J Billadello.   

Abstract

We characterized the developmental expression of the brain creatine kinase (BCK) gene in the C2C12 myogenic cell line with the use of isoenzyme, Western blot, and Northern blot analyses. The results show that both BCK subunit protein and mRNA are upregulated early in myogenesis, and then downregulated in fully differentiated myotubes. To characterize the transcriptional regulatory mechanisms, a chimeric construct containing 1.2 kilobase pairs of 5'-flanking DNA from the human BCK gene placed upstream of the chloramphenicol acetyltransferase gene in the promoterless plasmid pSVOCAT was transiently transfected into C2C12 cells. In myoblasts and differentiating myotubes, the time course of expression of the constructs paralleled that of endogenous BCK mRNA. Additional constructs prepared by deleting 5'-flanking DNA were also transfected into C2C12 cells. All constructs were preferentially expressed in myoblasts relative to myotubes with absolute levels of expression increasing with deletion of 5'-flanking DNA. In nonmyogenic cells expression of the plasmids also increased with deletion of 5'-flanking DNA. An element from -1150 to -388 was isolated and found to be capable of suppressing expression of the BCK promoter and of heterologous promoters independent of orientation and position and hence to function as a silencer. Thus, BCK expression is mediated by sequences contained in the 5'-flanking DNA, including negative elements active in both C2C12 cells and nonmyogenic cells and elements that mediate the developmental expression of the BCK gene in C2C12 myogenic cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1956783      PMCID: PMC329132          DOI: 10.1093/nar/19.22.6231

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  95 in total

1.  Plasticity of the differentiated state.

Authors:  H M Blau; G K Pavlath; E C Hardeman; C P Chiu; L Silberstein; S G Webster; S C Miller; C Webster
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

Review 2.  Transcriptional repression in eukaryotes.

Authors:  R Renkawitz
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

3.  The mouse muscle creatine kinase cDNA and deduced amino acid sequences: comparison to evolutionarily related enzymes.

Authors:  J N Buskin; J B Jaynes; J S Chamberlain; S D Hauschka
Journal:  J Mol Evol       Date:  1985       Impact factor: 2.395

4.  cis-acting negative regulatory element of prolactin gene.

Authors:  Z X Zhang; V Kumar; R T Rivera; J Chisholm; D K Biswas
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  The human beta-interferon gene enhancer is under negative control.

Authors:  S Goodbourn; H Burstein; T Maniatis
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

6.  Expression of creatine kinase isoenzymes in myogenic cell lines.

Authors:  H Dym; D Yaffe
Journal:  Dev Biol       Date:  1979-02       Impact factor: 3.582

7.  Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene.

Authors:  R V Trask; A W Strauss; J J Billadello
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

8.  Postnatal repression of the alpha-fetoprotein gene is enhancer independent.

Authors:  S A Camper; S M Tilghman
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

9.  Positive and negative elements regulate human interleukin 3 expression.

Authors:  B Mathey-Prevot; N C Andrews; H S Murphy; S G Kreissman; D G Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

10.  Developmental regulation of alpha-fetoprotein genes in transgenic mice.

Authors:  R Krumlauf; R E Hammer; S M Tilghman; R L Brinster
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

View more
  8 in total

1.  Crystal structure of brain-type creatine kinase at 1.41 A resolution.

Authors:  M Eder; U Schlattner; A Becker; T Wallimann; W Kabsch; K Fritz-Wolf
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum: evidence for transcriptional regulation.

Authors:  Wei Shen; Dianna Willis; Yanping Zhang; Uwe Schlattner; Theo Wallimann; George R Molloy
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

3.  A combination of upstream and proximal elements is required for efficient expression of the mouse renin promoter in cultured cells.

Authors:  K Tamura; K Tanimoto; K Murakami; A Fukamizu
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

Review 4.  Molecular characterization of the creatine kinases and some historical perspectives.

Authors:  W Qin; Z Khuchua; J Cheng; J Boero; R M Payne; A W Strauss
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

5.  Expression of the Gs protein alpha-subunit disrupts the normal program of differentiation in cultured murine myogenic cells.

Authors:  C C Tsai; J E Saffitz; J J Billadello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

6.  Differential localization of the mRNA of the M and B isoforms of creatine kinase in myoblasts.

Authors:  I A Wilson; K M Brindle; A M Fulton
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

7.  POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element.

Authors:  V Budhram-Mahadeo; M Parker; D S Latchman
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.

Authors:  J Zhao; F I Schmieg; D T Simmons; G R Molloy
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.